Post-transplant hyperlipidaemia

Postgraduate Medical Journal

Volumn 73, Issue 866, 1997, Pages 785-793

  Jindal, Rahul M ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Atherosclerotic disease; Hyperlipidaemia; Lipid lowering drugs; Transplantation

Indexed keywords

ANTILIPEMIC AGENT; AZATHIOPRINE; CHOLESTEROL; COLESTYRAMINE; CYCLOSPORIN A; FISH OIL; FLUINDOSTATIN; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; LIPID; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; PREDNISOLONE; SIMVASTATIN; STEROID; TACROLIMUS;

ALLOGRAFT; ARTICLE; ATHEROSCLEROSIS; AWARENESS; CHOLELITHIASIS; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFICACY; EXERCISE; FAT INTAKE; GLUCOSE INTOLERANCE; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; HYPERURICEMIA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; MORBIDITY; MORTALITY; ORGAN TRANSPLANTATION; QUALITY OF LIFE; RHABDOMYOLYSIS;

EID: 0030665932     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.73.866.785     Document Type: Article

References (16)

1. Oliver MF. Statins prevent coronary heart disease. Lancet 1995; 346: 1378-9.
2. Raine AEG, Carter R, Mann JI, Chapman JR, Morris PJ. Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression. Transplant Proc 1987; 21: 1820-1.
3. McDiarmid SV, Gornbein JA, Fortunat M, et al. Serum lipid abnormalities in pediatric liver transplant patients. Transplantation 1992; 53: 109-15.
4. Gokal R, Mann JI, Moore RA, Morris PJ. Hyperlipidemia following renal transplantation. Q J Med 1979; 192: 507-17.
5. Munoz SJ, Deems RO, Moritz MJ, Martin P, Jarrel BE, Maddrey WC. Hyperlipidemia and obesity after orthotopic liver transplantation. Transplant Proc 1991; 23: 1480-3.
6. Dunn SP, Falkenstein K, Lawrence JP, et al. Monotherapy with cyclosporine for chronic immunosuppression in pediatric liver transplant recipients. Transplantation 1994; 57: 544.
7. Morrisett JD, Northrup SR, Gotto AM, et al. Effect of FK506 and cyclosporine on plasma cholesterol levels. Transplant Proc 1991; 23: 3185.
8. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-7.
9. Havel RJ, Rapaport E. Management of primary hyperlipidemia. N Engl J Med 1995; 332: 1491-8.
10. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-4.
11. Jindal RM. Posttransplant diabetes mellitus - a review. Transplantation 1994; 58: 1289-98.
12. Vatsala A, Weinberg RB, Schoenberg L, et al. Lipid abnormalities in cyclosporin-prednisone-treated renal transplant recipients. Transplantation 1989; 48: 37-43.
13. Taylor DO, Thompson JA, Hastillo A, et al. Hyperlipidemia after clinical heart transplantation. J Heart Transplant 1989; 8: 209.
14. Jindal RM, Sidner RA, Hughes D, et al. Metabolic problems in recipients of liver transplants. Clin Transplant 1996; 10: 213-7.
15. Gilman AG, Goodman LS. The pharmacological basis of therapeutics. New York: Pergamon, 1990.
16. deGroen P. Cyclosporine, low-density lipoprotein, and cholesterol. Mayo Clin Proc 1988; 262: 53-6.